Top

Published in:

01-02-2012 | Letter

Adult-onset Still’s disease in pregnancy

Authors: Motohisa Yamamoto, Tetsuya Tabeya, Chisako Suzuki, Yasuyoshi Naishiro, Hidetaka Yajima, Yui Shimizu, Mikiko Obara, Hiroyuki Yamamoto, Toshiaki Sugaya, Hiroki Takahashi, Kohzoh Imai, Yasuhisa Shinomura

Published in: Modern Rheumatology | Issue 1/2012

Excerpt

We report a case of adult-onset Still’s disease (AOSD) in a pregnant patient that was successfully treated using intravenous methylprednisolone, cyclosporine, and plasma exchange, allowing safe delivery. Pregnancy appears to be one risk factor for AOSD, and we summarize the relationship between AOSD and pregnancy. …

Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still’s disease. J Rheumatol. 1992;19:423–30.

Bywaters EG. Still’s disease in the adult. Ann Rheum Dis. 1971;30:121–33.PubMedCrossRef

Stein GH, Cantor B, Panush RS. Adult Still’s disease associated with pregnancy. Arthritis Rheum. 1980;23:248–50.PubMedCrossRef

Green J, Kanter Y, Barzilai D. Adult Still’s disease associated with pregnancy. Isr J Med Sci. 1982;18:1037–9.PubMed

Yebra Bango M, Garcia Paez JM, Solovera JJ, Merino MF, Girón González JA. Adult-onset Still’s disease: a case with onset during pregnancy. Arthritis Rheum. 1985;28:957.PubMedCrossRef

Katz WE, Starz TW, Winkelstein A. Recurrence of adult Still’s disease after pregnancy. J Rheumatol. 1990;17:373–4.PubMed

Leff RD. Recurrence of adult Still’s disease after pregnancy. J Rheumatol. 1990;17:1571–2.PubMed

De Miguel E, Cuesta M, Martin-Mola E, Gijón-Baños J. Adult Still’s disease and pregnancy. J Rheumatol. 1992;19:498.PubMed

Parry G, Goudevenos J, Williams DO. Coronary thrombosis postpartum in a young woman with Still’s disease. Clin Cardiol. 1992;15:305–7.PubMedCrossRef

10.

Le Loët X, Daragon A, Duval C, Thomine E, Lauret P, Humbert G. Adult Still’s disease and pregnancy. J Rheumatol. 1993;20:1158–61.PubMed

11.

Falkenbach A, Lembcke B, Schneider M, Wigand R, Mulert-Ernst R, Caspary W. Polyserositis in adult Still’s disease with onset during pregnancy. Clin Rheumatol. 1994;13:513–7.PubMedCrossRef

12.

Mahmud T, Hughes GR. Intravenous immunoglobulin in the treatment of refractory adult Still’s disease. J Rheumatol. 1999;26:2067–8.PubMed

13.

Liozon E, Ly K, Vidal E. Intravenous immunoglobulins for adult Still’s disease and pregnancy. Rheumatology (Oxford). 1999;38:1024–5.CrossRef

14.

Pan VL, Haruyama AZ, Guberman C, Kitridou RC, Wing DA. Newly diagnosed adult-onset Still disease in pregnancy. Obstet Gynecol. 2003;101(5 Pt 2):1112–6.PubMedCrossRef

15.

Mok MY, Lo Y, Leung PY, Lau CS. Pregnancy outcome in patients with adult onset Still’s disease. J Rheumatol. 2004;31:2307–9.PubMed

16.

Chen DY, Lan JL, Lin FJ, Hsieh TY, Wen MC. Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still’s disease. Ann Rheum Dis. 2004;63:1300–6.PubMedCrossRef

17.

Kawaguchi Y, Terajima H, Harigai M, Hara M, Kamatani N. Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still’s disease. Arthritis Rheum. 2001;44:1716–7.PubMedCrossRef

18.

19.

Ida A, Tsuji Y, Kanazawa R, et al. IL-18 in pregnancy; the elevation of IL-18 in maternal peripheral blood during labour and complicated pregnancies. J Reprod Immunol. 2000;47:65–74.PubMedCrossRef

Title: Adult-onset Still’s disease in pregnancy
Authors: Motohisa Yamamoto
Tetsuya Tabeya
Chisako Suzuki
Yasuyoshi Naishiro
Hidetaka Yajima
Yui Shimizu
Mikiko Obara
Hiroyuki Yamamoto
Toshiaki Sugaya
Hiroki Takahashi
Kohzoh Imai
Yasuhisa Shinomura
Publication date: 01-02-2012
Publisher: Springer Japan
Published in: Modern Rheumatology / Issue 1/2012
Print ISSN: 1439-7595
Electronic ISSN: 1439-7609
DOI: https://doi.org/10.1007/s10165-011-0490-z

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2012

A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details

The Japanese version of the 2010 American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and the Fibromyalgia Symptom Scale: reliability and validity

Elevation of serum KL-6 levels in 3 patients with rheumatoid arthritis treated with adalimumab

Involvement of IL-33 in the pathogenesis of rheumatoid arthritis: the effect of etanercept on the serum levels of IL-33

Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis

A trans-ethnic genetic study of rheumatoid arthritis identified FCGR2A as a candidate common risk factor in Japanese and European populations

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials